• Mon news: Ventyx gets boost from Sanofi. PhRMA IRA legal challenge gets new life. AZ breast cancer drug disappoints. Teva’s once-monthly schizophrenia med. AZ gets FDA approval for first self-administered flu vaccine. See more on our front page

Johnson & Johnson Rises on Q4 Beats, Coronavirus Vaccine Hopes

Quote
cafead

cafead

Administrator
Staff member
  • cafead   Jan 26, 2021 at 11:42: PM
via Johnson & Johnson (NYSE:JNJ) delivered an encouraging set of quarterly results on Tuesday, which included a promising -- albeit limited -- update on its coronavirus vaccine candidate.

article source
 

<



Similar threads

cafead
Johnson &amp; Johnson adds $1.1 billion to proposed talc settlement
Replies
0
Views
26
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
Targeting AZ&#039;s Tagrisso, Johnson &amp; Johnson&#039;s Rybrevant combo wins key FDA nod in first-line lung cancer
Replies
0
Views
23
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
Johnson &amp; Johnson boosts full-year outlook on strong Q2 sales numbers
Replies
0
Views
32
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
Johnson &amp; Johnson proposes $505M settlement with bankrupt talc miners
Replies
0
Views
55
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
How Pfizer, Bristol Myers Squibb and Johnson &amp; Johnson Are Confronting Patent Cliffs
Replies
0
Views
51
Pharma/Biotech Companies - In the News
cafead
cafead
Top Bottom
Back
Quote